These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 8097098)

  • 1. Human T-lymphotropic virus (HTLV) types I and II: seroprevalence among intravenous drug users in continental France. Retrovirus Study Group of the French Society of Blood Transfusion.
    Coste J; Lemaire JM; Couroucé AM; Canavaggio M
    AIDS; 1993 Mar; 7(3):440-1. PubMed ID: 8097098
    [No Abstract]   [Full Text] [Related]  

  • 2. [Confirmation of the presence in Cuba of human T-cell lymphotropic virus type I using the polymerase chain reaction].
    Rolo Gómez F; De Armas MB; Mato Luis J; Lubián Caballero AL; Díaz Torres H
    Rev Cubana Med Trop; 1997; 49(3):204-8. PubMed ID: 9685988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroepidemiology and clinical aspects of human T-cell lymphotropic virus type I/II infection in a cohort of intravenous drug users in New York City.
    Brown LS; Chu A; Allain JP; Lee H; Cerney M; Nemoto T
    N Y State J Med; 1991 Mar; 91(3):93-7. PubMed ID: 2047026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Determination of anti-HTLV-I/II antibodies: Experience in 28,897 blood donations in Buenos Aires].
    Blejer JL; Saguier MC; Salamone HJ; Carreras LA
    Sangre (Barc); 1995 Dec; 40(6):447-51. PubMed ID: 8850226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human T lymphotropic virus type I/II infection: prevalence and risk factors in individuals testing for HIV in counseling centers from Southern Brazil.
    Barcellos NT; Fuchs SC; Mondini LG; Murphy EL
    Sex Transm Dis; 2006 May; 33(5):302-6. PubMed ID: 16505751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sero-epidemiological study on the human T-cell leukaemia virus type I/II infection in the east coastal areas of Fujian province].
    Wang HR; Yan YS; Zhang QW; Zheng J; Liu JM; Feng YY; Wu SQ; Wu JH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May; 25(5):428-30. PubMed ID: 15231172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroepidemiology of HTLV-I/II in universal screening of blood donations in France.
    Couroucé AM; Pillonel J; Lemaire JM; Maniez M; Brunet JB
    AIDS; 1993 Jun; 7(6):841-7. PubMed ID: 8103342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is seroprevalence of HTLV-I/II among blood donors in India relevant?
    Kumar H; Gupta PK
    Indian J Pathol Microbiol; 2006 Oct; 49(4):532-4. PubMed ID: 17183844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The epidemiology and disease outcomes of human T-lymphotropic virus type II.
    Roucoux DF; Murphy EL
    AIDS Rev; 2004; 6(3):144-54. PubMed ID: 15595431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human T lymphotropic virus types I and II proviral sequences in Argentinian blood donors with indeterminate Western blot patterns.
    Mangano AM; Remesar M; del Pozo A; Sen L
    J Med Virol; 2004 Oct; 74(2):323-7. PubMed ID: 15332282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher human T lymphotropic virus (HTLV) provirus load is associated with HTLV-I versus HTLV-II, with HTLV-II subtype A versus B, and with male sex and a history of blood transfusion.
    Murphy EL; Lee TH; Chafets D; Nass CC; Wang B; Loughlin K; Smith D;
    J Infect Dis; 2004 Aug; 190(3):504-10. PubMed ID: 15243924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [HTLV-I and HTLV-II viruses: fifteen years after their description].
    Delaporte E
    Med Trop (Mars); 1995; 55(1):17-20. PubMed ID: 7637602
    [No Abstract]   [Full Text] [Related]  

  • 13. Seroprevalence of human T-lymphotropic virus type 1 and 2 in Korean blood donors.
    Kwon SY; Lim AH; Park JY; Han SH; Cho NS
    J Med Virol; 2008 Oct; 80(10):1864-7. PubMed ID: 18712809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HTLV infection among young injection and non-injection heroin users in Spain: prevalence and correlates.
    de la Fuente L; Toro C; Soriano V; Brugal MT; Vallejo F; Barrio G; Jiménez V; Silva T;
    J Clin Virol; 2006 Mar; 35(3):244-9. PubMed ID: 16143565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of HTLV-I/HTLV-II in blood donors in Buenos Aires (Argentina).
    Gutfraind Z; Blejer JL; Saguier MC; Gomez Carretero ML; Pirola DA; Carreras Vescio LA
    Vox Sang; 1994; 67(4):408-9. PubMed ID: 7701816
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prevalence of HTLV-I and HTLV-II infection in Puglia].
    Quarto M; Chironna M; Germinario C; Lopalco PL; Barbuti S
    Ann Ig; 1996; 8(6):649-55. PubMed ID: 9312232
    [No Abstract]   [Full Text] [Related]  

  • 17. [Type 1 and 2 human lymphotropic virus: new perspectives].
    Pardo F; Tirado MD; Sabater S; Granados J
    Enferm Infecc Microbiol Clin; 2010 Oct; 28(8):568; author reply 569. PubMed ID: 20444526
    [No Abstract]   [Full Text] [Related]  

  • 18. Human T lymphotropic virus types I and II western blot seroindeterminate status and its association with exposure to prototype HTLV-I.
    Yao K; Hisada M; Maloney E; Yamano Y; Hanchard B; Wilks R; Rios M; Jacobson S
    J Infect Dis; 2006 Feb; 193(3):427-37. PubMed ID: 16388491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of human T-cell leukemia virus types I and II in Switzerland.
    Böni J; Bisset LR; Burckhardt JJ; Joller-Jemelka HI; Bürgisser P; Perrin L; Gorgievski M; Erb P; Fierz W; Piffaretti JC; Schüpbach J;
    J Med Virol; 2004 Feb; 72(2):328-37. PubMed ID: 14695678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HTLV infection in ELISA-negative blood donors.
    Zehender G; Girotto M; De Maddalena C; Francisco G; Moroni M; Galli M
    AIDS Res Hum Retroviruses; 1996 May; 12(8):737-40. PubMed ID: 8744584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.